Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The injection itself can occur at any time regardless of food intake
The Journal of the Association of Physicians of India
In the REDEFINE 1 clinical trial, patients treated with the combination achieved a mean weight loss of 22.7% at 68 weeks, and more than 40% of participants achieved at least a 25% reduction in body weight
Cardiovascular considerations Both mazdutide and retatrutide improve cardiovascular risk markers, but the specifics differ in ways that matter for different patient populations
Retatrutide is an injection administered weekly, which others may find simpler than daily pills
Wegovy (semaglutide): MHRA-approved for chronic weight management
US$ 29.12
US$ 21.70
US$ 24.07
US$ 26.36
US$ 23.81
